Distinguished in Primitive Neuroectodermal Tumor (PNET)

Dr. Michael M. Dominello

Radiation Oncology
University Physician Group
4100 John R St, 
Detroit, MI 
Accepting New Patients
Distinguished in Primitive Neuroectodermal Tumor (PNET)
University Physician Group
4100 John R St, 
Detroit, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Dominello is a Radiation Oncologist in Detroit, Michigan. Dr. Dominello is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Breast Cancer, Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, and Angiosarcoma. Dr. Dominello is currently accepting new patients.

His clinical research consists of co-authoring 84 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Licenses
Radiology in MI
Hospital Affiliations
Karmanos Cancer Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
McLaren Health
  • HMO
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 3 Less Insurance Carriers -

Locations

UNIVERSITY PHYSICIAN GROUP
4100 John R St, Detroit, MI 48201

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
Enrollment Status: Completed
Publish Date: October 08, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Capecitabine, Chemotherapy, Erlotinib hydrochloride, Fluorouracil, Gemcitabine hydrochloride
Study Phase: Phase 3
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Temozolomide
Study Phase: Phase 2
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Enrollment Status: Completed
Publish Date: January 28, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
LUNAR: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure
LUNAR: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure
Enrollment Status: Completed
Publish Date: October 21, 2024
Intervention Type: Drug, Device
Study Drug: Immune checkpoint inhibitors or docetaxel
Study Phase: Phase 3
Phase II Trial of Concurrent Nivolumab in Urothelial Bladder Cancer With Radiation Therapy in Localized/Locally Advanced Disease for Chemotherapy Ineligible Patients [NUTRA]
Phase II Trial of Concurrent Nivolumab in Urothelial Bladder Cancer With Radiation Therapy in Localized/Locally Advanced Disease for Chemotherapy Ineligible Patients [NUTRA]
Enrollment Status: Completed
Publish Date: August 04, 2023
Intervention Type: Drug, Radiation
Study Drug: Nivolumab
Study Phase: Phase 2
Medical Physics Direct Patient Care Initiative - Communication Intervention Study Protocol
Medical Physics Direct Patient Care Initiative - Communication Intervention Study Protocol
Enrollment Status: Completed
Publish Date: October 07, 2022
Intervention Type: Other
Study Phase: Not Applicable
View 5 Less Clinical Trials

84 Total Publications

Three discipline collaborative radiation therapy (3DCRT) special debate: AI structure segmentation is better than clinician contouring for both OARs and targets.
Three discipline collaborative radiation therapy (3DCRT) special debate: AI structure segmentation is better than clinician contouring for both OARs and targets.
Journal: Journal of applied clinical medical physics
Published: May 30, 2025
Similar Doctors
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Inga S. Grills
Radiation Oncology
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Inga S. Grills
Radiation Oncology

Beaumont Medical Group- Specialty Services

3577 W 13 Mile Rd, 
Royal Oak, MI 
 (13.3 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Inga Grills is a Radiation Oncologist in Royal Oak, Michigan. Dr. Grills is rated as an Elite provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Arteriovenous Malformation, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Gamma Knife Radiosurgery, and Endoscopic Transnasal Transsphenoidal Surgery. Dr. Grills is currently accepting new patients.

Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Zachary A. Seymour
Radiation Oncology
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Zachary A. Seymour
Radiation Oncology

Beaumont Medical Group- Specialty Services

3601 W 13 Mile Rd, 
Royal Oak, MI 
 (13.2 miles away)
Experience:
16+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Zachary Seymour is a Radiation Oncologist in Royal Oak, Michigan. Dr. Seymour has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Prostate Cancer, Metastatic Brain Tumor, Posterior Fossa Tumor, Gamma Knife Radiosurgery, and Hormone Replacement Therapy (HRT). Dr. Seymour is currently accepting new patients.

Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Prakash Chinnaiyan
Radiation Oncology | Radiology
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Prakash Chinnaiyan
Radiation Oncology | Radiology

Beaumont Medical Group- Specialty Services

3577 W 13 Mile Rd, 
Royal Oak, MI 
 (13.3 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Prakash Chinnaiyan is a Radiation Oncologist and a Radiologist in Royal Oak, Michigan. Dr. Chinnaiyan is rated as an Elite provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Gamma Knife Radiosurgery. Dr. Chinnaiyan is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dominello's expertise for a condition
ConditionClose
    View All 33 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile